ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal

March 18, 1988

Centers Agree To Broader Phase 1 Availability; Cool to Idea Of Distributing Group C Drugs

November 16, 1990

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

October 13, 2000

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012

Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer

December 11, 1998